ERBB2 and cancer: The two new H-bonds formed (Figure 2b) are able to further stabilise the CR1/L2 interaction and by exposing the CR1 domain to dimerisation, can help to maintain an active ready form of the cat erbB-2 protein that, as previously demonstrated for human erbB-2 favours the cancer process by promoting signal transduction [59], [60].